Associated British Foods plc : Play the V-bottom
Entry price | Target | Stop-loss | Potential |
---|
GBX 1,951 |
GBX 2,031 |
GBX 1,908 |
+4.1% |
---|
The share has been severely punished after the contact of the upper limit of the bullish trend line also corresponding to the mid-term resistance at GBp 2031. However, it has positively reacted on the lower limit of the bullish channel, rebounding towards the GBp 1949 resistance.
Fundamentals of the company are very strong. Indeed, Surperformance rating emphasize the profitability with a net margin of 5.32% and an operating margin of 8.68% estimated for this year. Also, both in terms of earnings release quality and business predictability, the group gets excellent grades by our rating system. Eventually, EPS and revenue estimates are constantly revised upward by analysts from Thomson Reuters.
Graphically, the stock shows a V-bottom configuration with a slight pull-back around GBp 1888. This technical pattern should rapidly lead the security towards the GBp 2031 resistance.
Thus, taking into account good fundamentals and the technical pattern forming, investors could buy the stock above the short-term resistance to aim GBp 2031 firstly and the upper limit of the bullish channel secondly. A stop loss will be set below the effective entry point.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.